Esperion Therapeutics
ESPR
#6486
Rank
C$1.08 B
Marketcap
C$4.23
Share price
55.50%
Change (1 day)
180.48%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): C-$0.71

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.68. In 2024 the company made an earnings per share (EPS) of C-$0.31 an increase over its 2023 EPS that were of C-$2.88.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.71127.2%
2024C-$0.31-89.15%
2023C-$2.88-40.28%
2022C-$4.82-62.87%
2021C-$12.9980.38%
2020C-$7.2050.14%
2019C-$4.80-53.18%
2018C-$10.257.41%
2017C-$9.54110.81%
2016C-$4.5247.35%
2015C-$3.070.89%
2014C-$3.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.85-372.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$58.59-8,724.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$7.94 1,068.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.26-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.47-464.00%๐Ÿ‡บ๐Ÿ‡ธ USA